Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - bupivacaine hydrochloride monohydrate 0.528% equivalent to 0.5% anhydrous; bupivacaine hydrochloride monohydrate 0.528% equivalent to 0.5% anhydrous - solution for injection - 0.5 % - active: bupivacaine hydrochloride monohydrate 0.528% equivalent to 0.5% anhydrous excipient: sodium chloride sodium hydroxide water for injection active: bupivacaine hydrochloride monohydrate 0.528% equivalent to 0.5% anhydrous excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia · epidural block for surgery. · field block (minor and major nerve blocks and infiltration). analgesia · continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. · field block (minor nerve block and infiltration).

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 1:200000;  ; bupivacaine hydrochloride monohydrate 0.5%; adrenaline acid tartrate 1:200000; bupivacaine hydrochloride monohydrate 0.5% - solution for injection - 1:200000/0.5% - active: adrenaline acid tartrate 1:200000   bupivacaine hydrochloride monohydrate 0.5% excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 1:200000 bupivacaine hydrochloride monohydrate 0.5% excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia · epidural block for surgery. · field block (minor and major nerve blocks and infiltration). analgesia · continuous epidural infusion or intermittent bolus epidural administration for analgesia in postoperative pain or labour pain. · field block (minor nerve block and infiltration).

Novi Zeland - engleski - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - adrenaline acid tartrate 1:400000;  ; bupivacaine hydrochloride monohydrate 0.25%; adrenaline acid tartrate 1:400000; bupivacaine hydrochloride monohydrate 0.25% - solution for injection - 1:400000/0.25% - active: adrenaline acid tartrate 1:400000   bupivacaine hydrochloride monohydrate 0.25% excipient: hydrochloric acid sodium chloride sodium metabisulfite water for injection active: adrenaline acid tartrate 1:400000 bupivacaine hydrochloride monohydrate 0.25% excipient: hydrochloric acid sodium chloride sodium hydroxide sodium metabisulfite water for injection - marcain solutions are indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia · epidural block for surgery. · field block (minor and major nerve blocks and infiltration).

Irska - engleski - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - bupivacaine hydrochloride, epinephrine bitartrate - solution for injection - 0.25/0.5%w %v/v - amides

Irska - engleski - HPRA (Health Products Regulatory Authority)

astrazeneca uk limited - bupivacaine hydrochloride, epinephrine bitartrate - solution for injection - 0.5%/0.55% %v/v - amides

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

carestream health inc. - bupivacaine hydrochloride anhydrous (unii: aka908p8j1) (bupivacaine - unii:y8335394ro), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - bupivacaine hydrochloride anhydrous 5 mg in 1 ml - marcaine® 0.5% with epineprhine 1:200,000 is indicated for the production of local anesthesia for dental procedures by infiltration injection or nerve block in adults. marcaine® 0.5% with epinephrine 1:200,000 is not recommended for children. marcaine® 0.5% with epinephrine 1:200,000, is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide type or to other components of bupivacaine solutions.

Irska - engleski - HPRA (Health Products Regulatory Authority)

aspen pharma trading limited - bupivacaine hydrochloride; adrenaline tartrate - solution for injection - 0.25%w/v+5 microgram(s)/millilitre - amides; bupivacaine, combinations

Irska - engleski - HPRA (Health Products Regulatory Authority)

aspen pharma trading limited - adrenaline tartrate; bupivacaine hydrochloride - solution for injection - 0.5%/0.55% percent volume/volume - amides; bupivacaine, combinations

Australija - engleski - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - fentanyl citrate, quantity: 7.86 microgram/ml (equivalent: fentanyl, qty 5 microgram/ml); bupivacaine hydrochloride, quantity: 1.25 mg/ml (equivalent: bupivacaine hydrochloride monohydrate, qty 1.32 microgram/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; water for injections - indiactions as at 18 april 2000: marcain 0.125% with fentanyl 5 micrograms/ml is intended for post-operative or obstetric epidural analgesia.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

septodont, inc. - bupivacaine hydrochloride anhydrous (unii: aka908p8j1) (bupivacaine - unii:y8335394ro), epinephrine bitartrate (unii: 30q7ki53ak) (epinephrine - unii:ykh834o4bh) - marcaine® 0.5% (5 mg/ml) with epinephrine 1:200,000 injection is indicated for the production of local anesthesia for dental procedures by infiltration injection or nerve block in adults. marcaine® 0.5% (5 mg/ml) with epinephrine 1:200,000 injection is not recommended for children. marcaine® 0.5% (5 mg/ml) with epinephrine 1:200,000 injection, is contraindicated in patients with a known hypersensitivity to it or to any local anesthetic agent of the amide type or to other components of bupivacaine solutions.